Cargando…

Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection

The gastrointestinal (GI) tract is a complex and well-balanced milieu of anatomic and immunological barriers. The epithelial surface of the GI tract is colonized by trillions of microorganisms, known as the gut microbiota, which is considered an “organ” with distinctive endocrine and immunoregulator...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouyang, Jing, Isnard, Stéphane, Lin, John, Fombuena, Brandon, Peng, Xiaorong, Nair Parvathy, Seema, Chen, Yaokai, Silverman, Michael S., Routy, Jean-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423874/
https://www.ncbi.nlm.nih.gov/pubmed/32850913
http://dx.doi.org/10.3389/fmed.2020.00421
_version_ 1783570213938135040
author Ouyang, Jing
Isnard, Stéphane
Lin, John
Fombuena, Brandon
Peng, Xiaorong
Nair Parvathy, Seema
Chen, Yaokai
Silverman, Michael S.
Routy, Jean-Pierre
author_facet Ouyang, Jing
Isnard, Stéphane
Lin, John
Fombuena, Brandon
Peng, Xiaorong
Nair Parvathy, Seema
Chen, Yaokai
Silverman, Michael S.
Routy, Jean-Pierre
author_sort Ouyang, Jing
collection PubMed
description The gastrointestinal (GI) tract is a complex and well-balanced milieu of anatomic and immunological barriers. The epithelial surface of the GI tract is colonized by trillions of microorganisms, known as the gut microbiota, which is considered an “organ” with distinctive endocrine and immunoregulatory functions. Dysregulation of the gut microbiota composition, termed dysbiosis, has been associated with epithelial damage and translocation of microbial products into the circulating blood. Dysbiosis, increased gut permeability and chronic inflammation play a major role on the clinical outcome of inflammatory bowel diseases, graft-vs.-host disease (GVHD) and HIV infection. In this review, we focus on GVHD and HIV infection, conditions sharing gut immune damage leading to dysbiosis. The degree of dysbiosis and level of epithelial gut damage predict poor clinical outcome in both conditions. Emerging interventions are therefore warranted to promote gut microbiota homeostasis and improve intestinal barrier function. Interventions such as anti-inflammatory medications, and probiotics have toxicity and/or limited transitory effects, justifying innovative approaches. Fecal microbiota transplantation (FMT) is one such approach where fecal microorganisms are transferred from healthy donors into the GI tract of the recipient to restore microbiota composition in patients with Clostridium difficile-induced colitis or inflammatory bowel diseases. Preliminary findings point toward a beneficial effect of FMT to improve GVHD and HIV-related outcomes through the engraftment of beneficial donor bacteria, notably those producing anti-inflammatory metabolites. Herein, we critically review the potential for FMT in alleviating dysbiosis and gut damage in patients with GVHD or HIV-infection. Understanding the underlying mechanism by which FMT restores gut function will pave the way toward novel scalable and targeted interventions.
format Online
Article
Text
id pubmed-7423874
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-74238742020-08-25 Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection Ouyang, Jing Isnard, Stéphane Lin, John Fombuena, Brandon Peng, Xiaorong Nair Parvathy, Seema Chen, Yaokai Silverman, Michael S. Routy, Jean-Pierre Front Med (Lausanne) Medicine The gastrointestinal (GI) tract is a complex and well-balanced milieu of anatomic and immunological barriers. The epithelial surface of the GI tract is colonized by trillions of microorganisms, known as the gut microbiota, which is considered an “organ” with distinctive endocrine and immunoregulatory functions. Dysregulation of the gut microbiota composition, termed dysbiosis, has been associated with epithelial damage and translocation of microbial products into the circulating blood. Dysbiosis, increased gut permeability and chronic inflammation play a major role on the clinical outcome of inflammatory bowel diseases, graft-vs.-host disease (GVHD) and HIV infection. In this review, we focus on GVHD and HIV infection, conditions sharing gut immune damage leading to dysbiosis. The degree of dysbiosis and level of epithelial gut damage predict poor clinical outcome in both conditions. Emerging interventions are therefore warranted to promote gut microbiota homeostasis and improve intestinal barrier function. Interventions such as anti-inflammatory medications, and probiotics have toxicity and/or limited transitory effects, justifying innovative approaches. Fecal microbiota transplantation (FMT) is one such approach where fecal microorganisms are transferred from healthy donors into the GI tract of the recipient to restore microbiota composition in patients with Clostridium difficile-induced colitis or inflammatory bowel diseases. Preliminary findings point toward a beneficial effect of FMT to improve GVHD and HIV-related outcomes through the engraftment of beneficial donor bacteria, notably those producing anti-inflammatory metabolites. Herein, we critically review the potential for FMT in alleviating dysbiosis and gut damage in patients with GVHD or HIV-infection. Understanding the underlying mechanism by which FMT restores gut function will pave the way toward novel scalable and targeted interventions. Frontiers Media S.A. 2020-08-06 /pmc/articles/PMC7423874/ /pubmed/32850913 http://dx.doi.org/10.3389/fmed.2020.00421 Text en Copyright © 2020 Ouyang, Isnard, Lin, Fombuena, Peng, Nair Parvathy, Chen, Silverman and Routy. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Ouyang, Jing
Isnard, Stéphane
Lin, John
Fombuena, Brandon
Peng, Xiaorong
Nair Parvathy, Seema
Chen, Yaokai
Silverman, Michael S.
Routy, Jean-Pierre
Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection
title Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection
title_full Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection
title_fullStr Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection
title_full_unstemmed Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection
title_short Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection
title_sort treating from the inside out: relevance of fecal microbiota transplantation to counteract gut damage in gvhd and hiv infection
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423874/
https://www.ncbi.nlm.nih.gov/pubmed/32850913
http://dx.doi.org/10.3389/fmed.2020.00421
work_keys_str_mv AT ouyangjing treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection
AT isnardstephane treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection
AT linjohn treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection
AT fombuenabrandon treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection
AT pengxiaorong treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection
AT nairparvathyseema treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection
AT chenyaokai treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection
AT silvermanmichaels treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection
AT routyjeanpierre treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection